作者
David A Lieberman, Douglas K Rex, Sidney J Winawer, Francis M Giardiello, David A Johnson, Theodore R Levin
发表日期
2012/9/1
来源
Gastroenterology
卷号
143
期号
3
页码范围
844-857
出版商
Elsevier
简介
Screening for colorectal cancer (CRC) in asymptomatic patients can reduce the incidence and mortality of CRC. In the United States, colonoscopy has become the most commonly used screening test. Adenomatous polyps are the most common neoplasm found during CRC screening. There is evidence that detection and removal of these cancer precursor lesions may prevent many cancers and reduce mortality. 1 However, patients who have adenomas are at increased risk for developing metachronous adenomas or cancer compared with patients without adenomas. There is new evidence that some patients may develop cancer within 3–5 years of colonoscopy and polypectomy—so-called interval cancers. Ideally, screening and surveillance intervals should be based on evidence showing that interval examinations prevent interval cancers and cancer-related mortality. We have focused on the interval diagnosis of …
引用总数
2012201320142015201620172018201920202021202220232024111251902162362272322271951791219060